Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...

Weight loss drugs have risen in popularity in the recent years, but a disconnect remains between those who need the drugs and ...

"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...

Americans elect their leaders on the premise that those individuals will be capable of making the right decisions on difficult, as well as easy, issues. An issue on which members of Congress might ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...

As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.

Imagine reversing a life-altering condition without the use of drugs. One British GP is doing exactly that, and his ...

President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and ...

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.